Skip to main content
TipRanks
Go Ultimate75% OFF

Ascendis Pharma (ASND) Q4 2025 Earnings Report

791 Followers

ASND Q4 2025 EPS Results

Actual EPS
-$0.60
Consensus EPS
-$0.09
Beat/Miss
Missed by -$0.52
One Year Ago EPS
-$0.70

ASND Q4 2025 Revenue Results

Actual Revenue
$288.07M
Expected Revenue
$270.01M
Beat/Miss
Beat by +$18.06M
YoY Revenue Growth
+55.28%

Earnings Announcement Details

Quarter
Q4 2025
Date
02/11/2026
Time
After Close
Conference Call
Wednesday, February 11, 2026
ASND Upcoming Earnings

Ascendis Pharma's next earnings date is estimated for February 17, 2027, based on past reporting schedules.

Q4 2025 Earnings Call Audio

ASND Q4 2025 Earnings Call
0:00 / 0:00

Q4 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

ASND Earnings History

ASND earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 17, 20272026 (Q4)1.78--0.6――
Nov 12, 20262026 (Q3)0.871.19-1.1208.00% (+2.29)
Aug 13, 20262026 (Q2)1.653.11-0.9445.12% (+4.01)
May 07, 20262026 (Q1)―10.72-1.74717.09% (+12.46)
Feb 11, 20262025 (Q4)-0.09-0.60-0.714.06% (+0.10)
Nov 12, 20252025 (Q3)-0.27-1.10-1.8941.86% (+0.79)
Aug 07, 20252025 (Q2)-1.41-0.90-2.157.07% (+1.20)
May 01, 20252025 (Q1)-1.61-1.74-2.5331.30% (+0.79)
Feb 12, 20252024 (Q4)-1.08-0.70-1.6958.44% (+0.99)
Nov 14, 20242024 (Q3)-1.72-1.89-2.9636.06% (+1.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed